Table 1.
Baseline characteristics of included participants
| Total (n = 129) | |
|---|---|
| Age, median (IQR) | 35 (28–39) |
| Female gender | 83 (64) |
| Pregnant, n (% of females) | 1 (1) |
| Rural residence | 18 (11) |
| BMI—kg/m2, median (IQR) | 20 (18–22) |
| MUAC—cm, median (IQR) | 23 (21–26) |
| CD4 cell count—cells/μL, median (IQR) | 210 (110–309) |
| CD4 cell count <100 cells/μL | 29 (23) |
| CD4 cell count <200 cells/μL | 57 (45) |
| Hemoglobin—g/dL, median (IQR) | 12 (11–13) |
| Study nurse investigations | |
| Currently diagnosed with TB | 6 (5) |
| WHO HIV disease stage | |
| 1–2 | 58 (47) |
| 3 | 60 (48) |
| 4 | 6 (5) |
| Neck stiffness | 4 (3.2) |
| Neurologic deficit | 0 (0) |
| Confusion | 0 (0) |
| Self-reported symptoms | |
| Fever | 48 (37.5) |
| Night sweat | 41 (32.3) |
| Weight loss | 58 (45.0) |
| Fatigue | 50 (40.3) |
| Cough | 33 (25.6) |
| Diarrhea | 19 (14.7) |
| Headache | 64 (49.6) |
IQR interquartile range, BMI body-mass index, MUAC mid-upper arm circumference
Data presented as n (%), if not stated otherwise